Bioactive constituents of wood rot extract of tea, Camellia sinensis L.O. Kuntze against alates of low country live wood termite Glyptotermes dilatatus Bugnion and Popoff (Isoptera: Kalotermitidae).

Low country live wood termite (LCLWT), Glyptotermes dilatatus is attractive to rotted stumps of tea plant, Camellia sinensis. Rotted stumps are formed due to the attack of wood rot fungi in pruned stems. The objective of the present study was to investigate the response of LCLWT to extracts of rotted and healthy stems of susceptible tea cultivars, TRI 2023 and TRI 4042 and tolerant cultivars, TRI 2027 and TRI 4049 and isolate the LCLWT attractive fractions of tea stem extract. Since pieces of rotted stem of both susceptible and tolerant tea cultivars were more attractive to the alates than that of healthy stems, effects of EtOAc extracts of rotted and healthy stems of four tea cultivars were compared on behavior of the alates. The results revealed that the alates positively responded to extracts of rotted tea stems of four tea cultivars than that of healthy tea stems. Therefore hexane, chloroform and aqueous methanol fractions of the extracts of rotted stems were tested against alates using orientation bioassays. Results revealed that the hexane fraction of rotted stem of each cultivar was more attractive than that of the chloroform and methanol fractions. The results of bioassay guided fractionation of the hexane fraction using column chromatography revealed the presence of two bioactive sub-fractions suggesting non-polar compounds in rotted tea wood are more attractive to G. dilatatus than other sub-fractions. These two fractions can be used to develop a trapping mechanism to strengthen present IPM program of LCLWT.

Substance P concentration and history of headache in relation to postlumbar puncture headache: towards prevention.

Medical treatment of postlumbar puncture headache (post-LP HA) is often difficult and ineffective. Prevention would be preferable to more invasive procedures, including blood patch. The aim was to determine the incidence of post-LP HA in two suspected high risk groups compared with the general outpatient population. Based on previous research, it was hypothesised that a low substance P concentration, or a history of chronic headache, or both would be associated with a higher risk of post-LP HA. A total of 310 randomly selected patients undergoing diagnostic lumbar puncture in the outpatient neurology clinic over 30 consecutive months were studied. Follow up was by headache questionnaire or phone survey after diagnostic lumbar puncture. Substance P was measured by radioimmunoassay on a subset of 102 samples of CSF. The overall incidence of post-LP HA was 38%. Patients with a measured substance P value < 1.3 pg/ml were three times as likely to have post-LP HA than those with a higher value. A history of chronic or recurrent headache was reported by 57% of those who developed post-LP HA. This group was also three times as likely to experience post-LP HA as those who did not have chronic headaches.

Substance P: correlation of CSF and plasma levels.

OBJECTIVE: To determine the correlation between cerebrospinal fluid and plasma concentrations of substance P. PATIENTS: 37 patients undergoing lumbar puncture for various diagnostic purposes. MEASUREMENTS: Samples of cerebrospinal fluid and blood were obtained at the same visit. Substance P was measured by radioimmunoassay technique. At least 4 separate measurements were conducted on each sample to insure accuracy. RESULTS: The mean plasma SP level was 1.195 (+/- 1.1). The mean cerebrospinal fluid substance P level was 1.075 (+/- .07). There was a statistically significant positive correlation between substance P level in the plasma and cerebrospinal fluid. The Pearson correlation coefficient was 0.656 (P < .0001) and the Spearman correlation coefficient was 0.698 (P < .0001). CONCLUSIONS: Plasma substance P levels closely correlate with cerebrospinal fluid substance P levels. This will simplify the measurement of substance P in the evaluation of therapeutic agents for headache.

Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats.

We determined the levels of angiotensin I (ANG I), angiotensin II (ANG II), and the heptapeptide angiotensin(1-7) [ANG(1-7)] in the blood and brain of female Hannover Sprague-Dawley (SD) and transgenic hypertensive rats [mRen-2]27 by radioimmunoassay and high performance liquid chromatography. Hypertension was accompanied by higher plasma concentrations of ANG II, no statistical changes in ANG(1-7), and no differences in plasma ANG I levels. In the hypothalamus of transgenic rats, concentrations of ANG II and ANG(1-7) averaged 827% and 168% above values in SD rats (p < 0.005) whereas both ANG I and ANG II increased in the medulla oblongata. The data showed that the established phase of hypertension in rats harboring the mouse Ren-2 gene is associated with overexpression of the renin-angiotensin system in brain regions participating in the endocrine regulation of blood pressure.

Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart.

Neuropeptide Y (NPY) and norepinephrine are released together on sympathetic activation. To compare the time courses of NPY and norepinephrine washout from cardiac tissues, we measured the overflow of NPY-like immunoreactivity (NPY-LI) and norepinephrine in coronary sinus blood before, during, and after 3-minute trains of ansae subclaviae stimulation in 13 anesthetized dogs. We also measured vagally induced cardiac cycle length responses before and after ansae stimulation. Ansae stimulation increased NPY-LI and norepinephrine overflow from the heart in a frequency-dependent manner (p less than 0.02). After stimulation of the ansae at 5 and 10 Hz, the peak norepinephrine overflows decayed by 90% within 2 minutes, but the NPY-LI overflows required 17 +/- 11 and 35 +/- 21 minutes, respectively, to decay by 90%. Cardiac vagal effects were inhibited after 5- and 10-Hz ansae stimulations, and the peak inhibitions decayed by 90% after 19 +/- 7 and 39 +/- 16 minutes, respectively. The 90% decay times of the NPY-LI overflows were longer (p less than 0.003) than those of the norepinephrine overflows but did not differ significantly (p greater than 0.4) from the 90% decay times of the inhibition of vagal effects. We characterized NPY-LI in coronary sinus and arterial plasma by reversed-phase high-performance liquid chromatography. Before ansae stimulation, the main peak of NPY-LI in the plasma had a retention time similar to that of the oxidized human NPY-(1-36) standard. During ansae stimulation, however, there was a substantial increase in the peak of NPY-LI that eluted in a position similar to that of the monoxidized human NPY-(1-36) standard. These data support the hypothesis that neurally released NPY mediates the sympathetically evoked inhibition of vagal effects and indicate that the time course of removal of NPY from the heart differs substantially from that of norepinephrine. Moreover, under basal conditions, most NPY in the circulation is present in the oxidized form or as a fragment of the 36-amino-acid peptide. In contrast, cardiac sympathetic stimulation evokes the overflow of monoxidized NPY-(1-36) into the coronary sinus plasma.